[Hodgkin's disease occurring 4 years after alpha-chain disease in complete remission (author's transl)]. 1980

H Monges, and L Aubert, and J P Remacle, and A Chamlian, and B Mathieu, and A Cougard, and R Quilichini, and P Chaffanjon

UI MeSH Term Description Entries
D007137 Immunoglobulin alpha-Chains The class of heavy chains found in IMMUNOGLOBULIN A. They have a molecular weight of approximately 58 kDa and contain about 470 amino acid residues arranged in four domains and an oligosaccharide component bound covalently to their Fc fragment constant region. Ig alpha Chains,Immunoglobulins, alpha-Chain,Immunoglobulin alpha-Chain,alpha-Chain Immunoglobulins,alpha-Immunoglobulin Heavy Chain,alpha-Immunoglobulin Heavy Chains,Chains, Ig alpha,Heavy Chain, alpha-Immunoglobulin,Heavy Chains, alpha-Immunoglobulin,Immunoglobulin alpha Chain,Immunoglobulin alpha Chains,Immunoglobulins, alpha Chain,alpha Chain Immunoglobulins,alpha Chains, Ig,alpha Immunoglobulin Heavy Chain,alpha Immunoglobulin Heavy Chains,alpha-Chain, Immunoglobulin,alpha-Chains, Immunoglobulin
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D006362 Heavy Chain Disease A disorder of immunoglobulin synthesis in which large quantities of abnormal heavy chains are excreted in the urine. The amino acid sequences of the N-(amino-) terminal regions of these chains are normal, but they have a deletion extending from part of the variable domain through the first domain of the constant region, so that they cannot form cross-links to the light chains. The defect arises through faulty coupling of the variable (V) and constant (C) region genes. Franklin Disease,gamma-Chain Disease,mu-Chain Disease,Franklin's Disease,Franklins Disease,Heavy Chain Diseases,gamma Chain Disease,gamma-Chain Diseases,mu Chain Disease,mu-Chain Diseases
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

H Monges, and L Aubert, and J P Remacle, and A Chamlian, and B Mathieu, and A Cougard, and R Quilichini, and P Chaffanjon
June 1980, Haematologica,
H Monges, and L Aubert, and J P Remacle, and A Chamlian, and B Mathieu, and A Cougard, and R Quilichini, and P Chaffanjon
September 1975, Cancer,
H Monges, and L Aubert, and J P Remacle, and A Chamlian, and B Mathieu, and A Cougard, and R Quilichini, and P Chaffanjon
January 1978, Pathologie-biologie,
H Monges, and L Aubert, and J P Remacle, and A Chamlian, and B Mathieu, and A Cougard, and R Quilichini, and P Chaffanjon
January 1978, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
H Monges, and L Aubert, and J P Remacle, and A Chamlian, and B Mathieu, and A Cougard, and R Quilichini, and P Chaffanjon
August 1999, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
H Monges, and L Aubert, and J P Remacle, and A Chamlian, and B Mathieu, and A Cougard, and R Quilichini, and P Chaffanjon
January 1990, Leukemia & lymphoma,
H Monges, and L Aubert, and J P Remacle, and A Chamlian, and B Mathieu, and A Cougard, and R Quilichini, and P Chaffanjon
November 1985, Presse medicale (Paris, France : 1983),
H Monges, and L Aubert, and J P Remacle, and A Chamlian, and B Mathieu, and A Cougard, and R Quilichini, and P Chaffanjon
January 1981, Archives francaises de pediatrie,
H Monges, and L Aubert, and J P Remacle, and A Chamlian, and B Mathieu, and A Cougard, and R Quilichini, and P Chaffanjon
November 1979, La Nouvelle presse medicale,
H Monges, and L Aubert, and J P Remacle, and A Chamlian, and B Mathieu, and A Cougard, and R Quilichini, and P Chaffanjon
December 1997, Leukemia & lymphoma,
Copied contents to your clipboard!